Efficacy and safety of fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide among people living with HIV-1: A systematic review and meta-analysis

被引：0
|
作者：
Wang, W. [1 ]
Zhao, S. [1 ]
Li, S. [1 ]
Huang, X. [1 ]
机构：
[1] Capital Med Univ, Clin & Res Ctr Infect Dis, Beijing Youan Hosp, Beijing, Peoples R China
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Y818
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [1] Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
    I-Wen Chen
    Hsin-Yun Sun
    Chien-Ching Hung
    Infectious Diseases and Therapy, 2021, 10 : 1331 - 1346
  • [2] Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
    Chen, I-Wen
    Sun, Hsin-Yun
    Hung, Chien-Ching
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1331 - 1346
  • [3] Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
    Emma D. Deeks
    Drugs, 2018, 78 : 1817 - 1828
  • [4] Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
    Deeks, Emma D.
    DRUGS, 2018, 78 (17) : 1817 - 1828
  • [5] Correction to: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
    Emma D. Deeks
    Drugs, 2019, 79 : 687 - 687
  • [6] Efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus dolutegravir combinations in HIV-1 adult population: A systematic review and meta-analysis
    Biju, Anto Amith J.
    Shaju, Aina
    Mudigubba, Manoj Kumar
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 325 - 326
  • [7] Patient-reported outcomes among people living with HIV on bictegravir/ emtricitabine/tenofovir alafenamide fixed-dose combination: Real-world data from Latin America
    Cecchini, D. M.
    Seleme, S.
    Mingrone, M. V.
    Diana Menendez, S.
    Mauas, R.
    Bottaro, E.
    Cassetti, I.
    HIV MEDICINE, 2023, 24 : 414 - 414
  • [8] Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials
    Orkin, Chloe
    Ajana, Faiza
    Kityo, Cissy
    Koenig, Ellen
    Natukunda, Eva
    Gandhi-Patel, Bhumi
    Wang, Hui
    Liu, Yapei
    Wei, Xuelian
    White, Kirsten
    Makadzange, Tariro
    Pikora, Cheryl
    McNicholl, Ian
    Collins, Sean E.
    Brainard, Diana
    Chuck, Susan K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (04) : 393 - 398
  • [9] Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
    Rolle, Charlotte-Paige
    Nguyen, Vu
    Patel, Kiran
    Cruz, Dan
    DeJesus, Edwin
    Hinestrosa, Federico
    MEDICINE, 2021, 100 (38)
  • [10] Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications
    Hanh Thi Pham
    Mesplede, Thibault
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 385 - 397
12345